Back to Insights and Updates for ProvidersMarch 2023

Reminder: MassHealth Unified Formulary

Tufts Health Together

Effective April 1, 2023, Tufts Health Together–MassHealth MCO Plan and ACPPs, in conjunction with the other Medicaid managed care organizations (MCOs) in the Commonwealth, will be utilizing MassHealth’s Unified Formulary for pharmacy medications and for select medical benefit drugs.

For pharmacy medications
As of that date, pharmacy coverage and criteria for Tufts Health Together consequently will mirror that of MassHealth. Tufts Health Together will maintain its own coverage and policies for select scenarios as granted by MassHealth when appropriate, including but not limited to, quantity limit exceptions. Please note that MassHealth will be updating its opioid management strategy in April to require prior authorization of opioid regimens exceeding 180 milligram of morphine equivalents (MME) per day when two or more opioids are prescribed. Members and providers are encouraged to review the MassHealth Drug List for pharmacy drug coverage and criteria.

For medical benefit drugs
For medical drug benefit coverage, in some cases we will utilize the MassHealth Drug List criteria, while in others Point32Health criteria will apply. In addition, we are removed prior authorization from some medical benefit drugs for Tufts Health Together members.

Prior authorization no longer required — The following medical benefit drugs and codes will be covered without prior authorization for Tufts Health Together members, effective April 1, 2023.

Drug Name Code Drug Name Code
Advate J7192 Koate J7190
Adynovate J7207 Kogenate J7192
Afstyla J7210 Kovaltry J7211
Alphanate J7186 Monoclate J7190
Alphanine J7193 Mononine J7193
Alprolix J7201 Novoeight J7182
Benefix J7195 Novoseven J7189
Coagadex J7175 Nuwiq J7209
Corifact J7180 Obizur J7188
Eloctate J7205 Profilnine J7194
Esperoct J7204 Rebinyn J7203
Feiba J7198 Recombinate J7192
Helixate J7192 Rixubis J7200
Hemlibra J7170 Sandostatin LAR Depot J2353
Hemofil J7190 Sevenfact J7212
Humate- P J7187 Tretten J7181
Idelvion J7202 Vonvendi J7179
Ixinity J7195 Wilate J7183
Jivi J7208 Xyntha J7185

Newly require prior authorization and will utilize MassHealth Drug List criteria — Beginning April 1, 2023, for coverage for Tufts Health Together Members, the following medical benefit drugs and codes will require prior authorization and must meet the criteria of the MassHealth Drug List.

Drug Name  Code  Drug Name  Code
Acthar J0800 Lupaeta pack J3590
Apretude J0739 Makena J1726
Aranesp J0881 Nexviazyme J0219
Berinert J0597 Spevigo J3490
Boniva J1740 Trelstar J3315
Camcevi J1952 Probuphine J0570
Cortrophin J0800 Quzyttir J3490
Firmagon J9155 Ruconest J0596
Eligard J9217 somavert J9307
Epogen J0885 Sinuva J7402
Kalbitor J1290 Trogarzo J3590
Gamastan J1460 Triptodur J3316
hydoxyprogesterone caproate J1729 Vantas J9225
Nplate J2796 Zinplava J0565
Lupron J9217 Zoladex J9202

Will continue to require prior authorizations and will use MassHealth Drug List criteria — The following drugs currently require prior authorization for Tufts Health Together members and will continue to do so. As of April 1, 2023, coverage criteria used will be MassHealth’s Drug List criteria.

Drug Name  Code  Drug Name  Code  Drug Name  Code
Abecma Q2055 Gamunex J1561 Releuko Q5125
Abilify Maintena J0401 Geodon J3486 Remicade J1745
Actemra J3262 Givlaari J0223 Remodulin J3285
Adakveo J0791 Granix J1447 Renflexis Q5104
Aduhelm J0172 Hizentra J1559 Retacrit Q5106
Amondys 45 J1426 HyQvia J1575 Risperdal Consta J2794
Amvuttra J0225 Ilaris J0638 Saphenlo J0491
Aristada J1944 Ilumya J3245 Signifor LAR J2502
Aristada Initio J1943 Inflectra Q5103 Simponi Aria J1602
Asceniv J1554 Infliximab J1745 Soliris J1300
Aveed J3145 Invega Hafye J2426 Spinraza J2326
Avsola Q5121 Invega Sustenna J2426 Spravato S0013
Benlysta J0490 Invega Trinza J2426 Stelara J3358
Berinert J0597 Krystexxa J2507 Supprelin LA J9226
Bivigam J1556 Kymriah Q2042 Synagis 90378
Botox J0585 Lemtrada J0202 Tecartus Q2053
Breyanzi Q2054 Leqvio J1306 Testopel J3490
Carvykti Q2056 Lupron 3.75 J1950 Tezspire J2356
Cinqair J2786 Lupron Depot J1950 Ultomiris J1303
Cinryze J0598 Luxturna J3398 Uplizna J1823
Cutaquip J1551 Myobloc J0587 Veletri J1325
Cuvitru J1555 Nivestym Q5110 Viltepso J1427
Dysport J0586 Nucala J2182 Vyepti J3032
Empaveli J3490 Ocrevus J2350 Vyondys 53 J1429
Enjaymo J1302 Octagam J1568 Vyvgart J9332
Entyvio J3380 Onpattro J0222 Xembify J1558
Epoprostenol J1325 Orencia J0129 Xeomin J0588
Evenity J3111 Oxlumo J0224 Xgeva J0897
Exondys51 J1428 Panzyga J1599 Xiaflex J0775
Fabrazyme J0180 Perseris J2798 Xolair J2357
Fasenra J0517 Prevymis J3490 Yescarta Q2041
Fensolvi J1951 Privigen J1459 Zarxio Q5101
Flebogamma J1572 Procrit J0885 Zolgensma J3399
Gammagard J1569 Proleukin J9015 Zulresso J1632
Gammagard S/D J1566 Prolia J0897 Zyprexa Relprevv J2358
Gammaked J1561 Radicava J1301
Gammaplex J1557 Reblozyl J0896

No change — Continue to require prior authorization and must meet criteria in Tufts Health Plan’s medical necessity guidelines.

Drug name Drug name
Abaxane Opdualag
Bevacizumab products Rituximab products
Brineura Scenesse
Cerezyme, Elelyso, VPRIV Skysona
Crystiva Tepezza
Evkeeza Trastuzumab products
Kanuma Vimizim
Nulibry Viscosupplements
Zynteglo

For more information on medical benefit drug coverage for Tufts Health Together members, please refer to the MassHealth Medical Benefit Unified Formulary Drugs Requiring PA Medical Necessity Guideline, as well as the MassHealth Drug List.


Audrey Kleinberg
Director, Provider Relations & Communications

Annmarie Dadoly
Senior Manager, Provider Communications

Joseph O’Riordan, Jesse Salvato, Stephen Wong
Writers

Kristin Edmonston
Production Coordinator

Kristina Cicelova
Graphic Designer